Latest Claudication Stories
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).
In a trial that included nearly 200 participants with peripheral artery disease (PAD), a home-based exercise intervention with a group-mediated cognitive behavioral intervention component improved walking performance and physical activity in patients with PAD.
Supervised exercise was shown to be more effective than stenting or medication for improved walking ability in patients with peripheral artery disease.
Peripheral arterial disease, or PAD, is a common condition affecting 12-20 percent of Americans age 65 and older that may be a signal of future heart attack and stroke—and many with the disease may be unaware they have it, says the Society of Interventional Radiology.
HUDSON, N.H., Nov. 2, 2010 /PRNewswire/ -- Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST(TM) Atrium Registry Ultrasound Study (iCARUS).
Even after initial procedures to clear blockages in leg arteries, hospitalizations and associated costs in patients with peripheral artery disease increase as the condition progresses.
Study Highlights: - Peripheral artery disease (PAD) is a progressive and costly disease, but remains under-diagnosed and under treated. - While current PAD treatments are effective at clearing artery blockages in the lower leg, high recurrence rates and the subsequent need for repeat procedures are costly. - More widespread use of diagnostic tests and preventive strategies early in the disease course may help slow PAD's progression and minimize the risk of poor outcomes. DALLAS, Oct.
- A political dynamiter.